
    
      Subject participation includes completion of informed consent, medical questionnaire, and
      email authorization. Subjects may provide a blood sample for alpha-1 antitrypsin genotype,
      phenotype and level. Lung and liver tissue may also be provided if available. Subjects may be
      contacted no more often than annually for updated information.

      This project has a certificate of confidentiality from NIH.
    
  